101 related articles for article (PubMed ID: 6498848)
41. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.
Macchiarini P; Fontanini G; Hardin MJ; Chuanchieh H; Bigini D; Vignati S; Pingitore R; Angeletti CA
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):80-9. PubMed ID: 8391612
[TBL] [Abstract][Full Text] [Related]
42. Impact of elastic staining on the staging of peripheral lung cancers.
Taube JM; Askin FB; Brock MV; Westra W
Am J Surg Pathol; 2007 Jun; 31(6):953-6. PubMed ID: 17527086
[TBL] [Abstract][Full Text] [Related]
43. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
[TBL] [Abstract][Full Text] [Related]
44. Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer.
Shintani Y; Ohta M; Iwasaki T; Ikeda N; Kanou T; Tomita E; Nakagawa K; Yasumitsu T; Ohno Y
J Thorac Cardiovasc Surg; 2009 Apr; 137(4):835-9. PubMed ID: 19327505
[TBL] [Abstract][Full Text] [Related]
45. Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.
Mizuno T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mochizuki T; Kawai O; Hasebe T; Ochiai A
Lung Cancer; 2008 Dec; 62(3):302-8. PubMed ID: 18486987
[TBL] [Abstract][Full Text] [Related]
46. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
47. Adenosquamous carcinoma of the lung and visceral pleural invasion.
Riquet M; Assouad J; Le Pimpec-Barthes F; Foucault C
Ann Thorac Surg; 2004 Oct; 78(4):1511-2; author reply 1512. PubMed ID: 15464536
[No Abstract] [Full Text] [Related]
48. Prognostic significance of visceral pleural invasion and tumor size in non-small cell lung cancer.
Hung JJ; Liu JS; Hsu WH
J Thorac Cardiovasc Surg; 2009 Jul; 138(1):260-1. PubMed ID: 19577109
[No Abstract] [Full Text] [Related]
49. Antitumour potential of pleural cavity macrophages in lung cancer patients without malignant effusion.
Kimura S; Sone S; Takahashi K; Uyama T; Ogura T; Monden Y
Br J Cancer; 1989 Apr; 59(4):535-9. PubMed ID: 2785397
[TBL] [Abstract][Full Text] [Related]
50. Human macrophage function in cancer: systemic and local changes detected by an assay for Fc receptor expression.
Rhodes J; Plowman P; Bishop M; Lipscomb D
J Natl Cancer Inst; 1981 Mar; 66(3):423-9. PubMed ID: 6937700
[TBL] [Abstract][Full Text] [Related]
51. Does pleural lavage cytology before thoracic closure predict both patient's prognosis and site of cancer recurrence after resection of esophageal cancer?
Doki Y; Kabuto T; Ishikawa O; Ohigashi H; Sasaki Y; Yamada T; Hiratsuka M; Miyashiro I; Kameyama M; Murata K; Imaoka S; Yasuda T; Nakaizumi A; Takenaka A
Surgery; 2001 Nov; 130(5):792-7. PubMed ID: 11685188
[TBL] [Abstract][Full Text] [Related]
52. [Strategy for surgical treatment for small peripheral carcinoma of the lung especially on systemic nodal dissection].
Watanabe A; Osawa H; Obama T; Watanabe T; Mawatari T; Ichimiya Y; Takahashi N; Abe T; Sato M; Abe S; Kusajima K
Kyobu Geka; 2004 Jan; 57(1):20-4. PubMed ID: 14733094
[TBL] [Abstract][Full Text] [Related]
53. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
[TBL] [Abstract][Full Text] [Related]
54. Defective cytostatic activity of pulmonary alveolar macrophages in primary lung cancer.
McDonald CF; Atkins RC
Chest; 1990 Oct; 98(4):881-5. PubMed ID: 2119952
[TBL] [Abstract][Full Text] [Related]
55. [Changes in the cytostatic and cytotoxic activities of the peripheral blood lymphocytes in the surgical treatment of lung cancer patients].
Polushina OA; Lian NV; Bogdashin IV
Vopr Onkol; 1992; 38(2):173-7. PubMed ID: 1300702
[TBL] [Abstract][Full Text] [Related]
56. Macrophages and metastasis--a biological approach to cancer therapy.
Fidler IJ
Cancer Res; 1985 Oct; 45(10):4714-26. PubMed ID: 2992766
[No Abstract] [Full Text] [Related]
57. [Activity of alveolar macrophages of experimental lung cancer and inhibition of cell proliferation].
Shen BH; He MC
Zhonghua Bing Li Xue Za Zhi; 1990 Dec; 19(4):279-81. PubMed ID: 2081352
[TBL] [Abstract][Full Text] [Related]
58. Cytostatic activity of pulmonary alveolar macrophages in lung cancer patients.
Kuda T
Chest; 1991 Nov; 100(5):1475. PubMed ID: 1935323
[No Abstract] [Full Text] [Related]
59. [Cellular infiltrates in lung cancer as a prognostic indicator].
Lipińska R; Kupis W; Roszkowski W
Pneumonol Pol; 1988 Jul; 56(7):297-301. PubMed ID: 3237472
[No Abstract] [Full Text] [Related]
60. Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cells.
Swinburne S; Moore M; Cole P
Cancer Immunol Immunother; 1985; 19(1):62-7. PubMed ID: 3844975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
